NX Pharmagen Inc. — Form D
NX Pharmagen Inc. of LOUISVILLE, KY, a company, filed a Form D exempt-offering notice with the SEC on 2013-06-25. The offering totals $1.0M, of which $773K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2013-06-25
- Form: D
- Accession: 0000911959-13-000023
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $773K
- Remaining: $227K
- Date of first sale: 2013-06-24
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-198568
Issuer
- Name: NX Pharmagen Inc.
- CIK: 0001508691
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 4350 BROWNSBORO ROAD, LOUISVILLE, KY, 40207
- Phone: 502-893-4570
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Brian D Brohman | Director | Louisville, KY |
| Pascal M Deschatelets | Director | Louisville, KY |
| Alan M Ezrin | Director | Louisville, KY |
| Cedric M Francois | Director | Louisville, KY |
| Fred M Mermelstein | Director | Louisville, KY |
| Robert M Saunders | Director | CHICAGO, IL |
| Brian D Brohman | Executive Officer | Louisville, KY |
| Alan M Ezrin | Executive Officer | Louisville, KY |
| Robert Saunders | Director | Chicago, IL |
| BRIAN BROHMAN | Director | LOUISVILLE, KY |
| BRIAN BROHMAN | Executive Officer | LOUISVILLE, KY |
| Alan Ezrin | Director | Louisville, KY |
| Fred Mermelstein | Director | Louisville, KY |
Other filings by this issuer (3)
More